Laboratoires Euromedis Société anonyme

LSE:0I0L Stock Report

Market Cap: €12.5m

Laboratoires Euromedis Société anonyme Past Earnings Performance

Past criteria checks 3/6

Laboratoires Euromedis Société anonyme's earnings have been declining at an average annual rate of -1.1%, while the Medical Equipment industry saw earnings growing at 1.9% annually. Revenues have been declining at an average rate of 61.4% per year. Laboratoires Euromedis Société anonyme's return on equity is 82.3%, and it has net margins of 58.5%.

Key information

-1.1%

Earnings growth rate

n/a

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate-61.4%
Return on equity82.3%
Net Margin58.5%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Laboratoires Euromedis Société anonyme makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

LSE:0I0L Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24311810
31 Mar 24341630
31 Dec 23371340
30 Sep 23434130
30 Jun 2350-6220
31 Mar 2352-6240
31 Dec 2254-6250
30 Sep 2262-7260
30 Jun 2269-8260
31 Mar 2291-3270
31 Dec 211122270
30 Sep 2115813280
30 Jun 2120423290
31 Mar 2119923290
31 Dec 2019323280
30 Sep 2014712280
30 Jun 201000270
31 Mar 2089-2270
31 Dec 1977-4280
31 Dec 1876-5260
31 Jan 1876-1320
31 Oct 1775-1290
31 Jul 17740250
30 Apr 17741180
31 Jan 17741110
31 Oct 16741120
31 Jul 16741120
30 Apr 16732120
31 Jan 16722120
31 Oct 15722120
31 Jul 15722110
30 Apr 15712110
31 Jan 15712110
31 Oct 14722110
31 Jul 14723110
30 Apr 14743110
31 Jan 14752110

Quality Earnings: 0I0L has a large one-off loss of €8.2M impacting its last 12 months of financial results to 30th June, 2024.

Growing Profit Margin: 0I0L became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0I0L has become profitable over the past 5 years, growing earnings by -1.1% per year.

Accelerating Growth: 0I0L has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 0I0L has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (39.9%).


Return on Equity

High ROE: 0I0L's Return on Equity (82.3%) is considered outstanding.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 11:34
End of Day Share Price 2024/12/09 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Laboratoires Euromedis Société anonyme is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stephanie LefebvreGilbert Dupont
Sandrine CauvinGilbert Dupont
Romain FreismuthPortzamparc BNP Paribas